Percheron Therapeutics (PER) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisInsider TradesBuy This Stock Percheron Therapeutics (ASX:PER) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)A$705.87KNumber OfInsiders Selling(Last 12 Months)0 Get PER Insider Trade Alerts Want to know when executives and insiders are buying or selling Percheron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PER Insider Buying and Selling by Quarter Percheron Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/30/2025James GarnerInsiderBuy2,500,000A$0.01A$25,000.003/31/2025Ben PriceInsiderBuy5,000,000A$0.01A$60,000.003/28/2025James GarnerInsiderBuy7,500,000A$0.01A$82,500.002/26/2025James GarnerInsiderBuy39,500,000A$0.01A$474,000.0012/31/2024Charmaine GittlesonInsiderBuy1,666,666A$0.01A$14,999.9912/24/2024James GarnerInsiderBuy1,500,000A$0.01A$10,500.0011/27/2024James GarnerInsiderBuy125,000A$0.07A$8,875.0011/14/2024James GarnerInsiderBuy375,000A$0.08A$30,000.00 (Data available from 1/1/2013 forward) PER Insider Trading Activity - Frequently Asked Questions Who is on Percheron Therapeutics' Insider Roster? The list of insiders at Percheron Therapeutics includes Ben Price, Charmaine Gittleson, and James Garner. Learn more on insiders at PER. Which Percheron Therapeutics insiders have been buying company stock? The following insiders have purchased PER shares in the last 24 months: Ben Price (A$60,000.00), Charmaine Gittleson (A$14,999.99), and James Garner (A$630,875.00). How much insider buying is happening at Percheron Therapeutics? Insiders have purchased a total of 58,166,666 PER shares in the last 24 months for a total of A$705,874.99 bought. More Insider Trading Tools from MarketBeat Related Companies LVMH-Moet Hennessy Louis Vuitton Insider Selling Anheuser-Busch InBev SA/NV Insider Selling Diageo Insider Selling Keurig Dr Pepper Insider Selling Ambev Insider Selling Pernod Ricard Insider Selling Vita Coco Insider Selling Westrock Coffee Insider Selling BRC Insider Selling Fresh Vine Wine Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (ASX:PER) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Percheron Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Percheron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access